Gainers

• Delcath Systems, Inc. (NASDAQ:DCTH) shares surged 57.7% to $4.93 in pre-market trading after the company reported the FDA approval of HEPZATO KIT™ for the treatment of adult patients with unresectable hepatic-dominant metastatic uveal melanoma.
• Sonim Technologies, Inc. (NASDAQ:SONM) rose 29.1% to $0.71 in pre-market trading after the company reported a 125% revenue increase in the second quarter.
• G Medical Innovations Holdings Ltd (NASDAQ:GMVD) shares gained 21% to $0.2299 in pre-market trading after falling over 7% on Monday.
• T2 Biosystems, Inc. (NASDAQ:TTOO) shares gained 18.4% to $0.4619 in pre-market trading after jumping 15% on Monday.
• The Arena Group Holdings, Inc. (NYSE:AREN) shares climbed 18.3% to $4.00 in pre-market trading after the company announced it signed a binding letter of intent to combine with Bridge Media Networks.
• LL Flooring Holdings, Inc. (NYSE:LL) shares rose 12.5% to $4.22 in pre-market trading after the company’s board announced exploration of strategic alternatives, including a sale.
• Castellum, Inc. (NYSE:CTM) rose 10.8% to $0.5320 in pre-market trading after posting better-than-expected quarterly sales.
• Siyata Mobile Inc. (NASDAQ:SYTA) shares rose 10.8% to $3.68 in pre-market trading following upbeat quarterly sales.
• Grove Collaborative Holdings, Inc. (NYSE:GROV) gained 10.5% to $2.42 in pre-market trading after the company posted strong quarterly sales and announced leadership changes.
• Taysha Gene Therapies, Inc. (NASDAQ:TSHA) gained 9.4% to $2.33 in pre-market trading. Taysha Gene Therapies shares jumped 188% on Monday after the company reported initial clinical data from the first adult Rett Syndrome patient dosed in the REVEAL Phase 1/2 trial and announced $150 million private placement financing.

Losers

Now Read This: Home Depot, Agilent Technologies And 3 Stocks To Watch Heading Into Tuesday